CompoAtlas

PMK 032 Eczema, Psoriasis and Pruritus Treatment

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Scrophularia nodosa

Source : Feuille

Extraction ratio : 10:1

Dry plant equivalent : 400 mg

40 mgNot calculated
Scrophularia nodosa

Source : Fleur

Extraction ratio : 10:1

Dry plant equivalent : 400 mg

40 mgNot calculated
Taraxacum officinale

Source : Racine

Extraction ratio : 10:1

Dry plant equivalent : 2,000 mg

200 mgNot calculated

Non-medicinal ingredients

Talc, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Capsule ; maximum: 2 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Dandelion is traditionally used in Herbal Medicine as an alternative to help relieve dermatological conditions such as eczema. Figwort is traditionally used in Herbal Medicine to relieve symptoms of chronic cutaneous diseases eczema, psoriasis and pruritus. Figwort is traditionally used in Herbal Medicine to relieve symptoms of eczema, psoriasis and pruritus.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Eczema, Psoriasis and Pruritus Treatment, Generic Eczema, Psoriasis and Pruritus Treatment
Licence holder
PMK Federal Regulatory Consultants Ltd.
NPN or DIN-HM
80037583
Status
Active licence
Licence date
19 November 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80037583

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PMK 032 Eczema, Psoriasis and Pruritus Treatment (PMK Federal Regulatory Consultants Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80037583-pmk-032-eczema-psoriasis-and-pruritus-treatment, updated 19 November 2012.

Enter to analyse, Shift+Enter for a new line